Back to search

Rsr Limited

03766047

active
Private Limited Company
england wales
Companies House
Health Score
85 / 100

Healthy

25/30
Filing
20/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Going concern doubt noted in accounts (-10)

Details

7 ROBIN LANE, LANCASTER, LA2 7AB
Incorporated 07/05/1999

Compliance

Last accounts

30/09/2024

full

Next accounts due

30/06/2026

On track

Confirmation statement

Last: 11/05/2026

Due 25/05/2027

On track

Industry

21100
Manufacture of basic pharmaceutical products

Officers

Dr Bernard Rees Smith

director · Since 15/06/1999

DIRECTOR

BRITISH · WALES · Age 82

Also on 6 other boards

Miss Janet Bradbury

director · Since 23/08/2016

SCIENTIST

BRITISH · WALES · Age 59

Also on 4 other boards

Dr Shu Chen

director · Since 23/08/2016

SCIENTIST

BRITISH · WALES · Age 59

Also on 5 other boards

Dr Jane Sanders

director · Since 23/08/2016

SCIENTIST

BRITISH · WALES · Age 59

Also on 4 other boards

Ms Jenny Louise Boak

secretary · Since 24/11/2023

Mrs Jenny Louise Boak

director · Since 30/10/2025

HEAD OF PERSONNEL

BRITISH · UNITED KINGDOM · Age 38

Also on 5 other boards

Persons with Significant Control

Dixondale Limited

75–100% shares
75–100% votes
Appoint directors

7, Robin Lane, Lancaster, LA2 7AB

Reg: 01662593 · Companies House · Limited By Shares

Notified 30/04/2025

Former PSCs

Dr Bernard Rees-Smith

Ceased 30/04/2025

CompanyRankvs 15+ SIC 21100 peers
80

Financial strength99th percentile among SIC peers · 25/25
Employees99th percentile among SIC peers · 15/15
LiquidityCurrent ratio 30.99× · 20/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
How is this score calculated?
Financial strength25/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going co

Key FinancialsYear ending 30/09/2023

Turnover

£22.2M

Annual revenue

Net Worth

£32.3M

Balance sheet strength

Cash

£19.6M

Cash in the bank

Profit Before Tax

£19.5M

Bottom line earnings

Net Current Assets

£32.0M

Working capital

Current Assets

£33.1M

Current Liabilities

£1.1M

Fixed Assets

£297k

Debtors

£11.8M

Cost of Sales

£10.0M

Gross Profit

£12.2M

Admin Expenses

£3.4M

Operating Profit

£19.4M

Profit After Tax

£17.7M

96avg. employees-3

Tax at Year End

Dividends paid£17.0M

People Costs

Wages & salaries£5.3M
NI contributions£619k

Balance Sheet

Assets less current liabilities£32.3M
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
202330.99+£657k
202215.97+£8.0M
202139.02
202026.03
201911.79

Derived from filed accounts. Not audited figures.